Icosavax, Inc. 3 SEC Filings

Filed On	Filing
14 Jun 2023	Form 3: Khan Amin, EVP, Head of Research & Dev.
14 Jun 2022	Form 3: Wassil Jim, Director No securities owned
05 Jan 2022	Form 3: Shiver John W., Director No securities owned
21 Sep 2021	Form 3: Bekiroglu Elizabeth, See Remarks Holds 27,750 shares of Common Stock
28 Jul 2021	Form 3: Gould Terry P, Director
28 Jul 2021	Form 3: Cearley Cassia, Chief Business Officer Holds 35,143 shares of Common Stock
28 Jul 2021	Form 3: Fields Heidi, Director
28 Jul 2021	Form 3: Kanesa-thasan Niranjan, Chief Medical Officer Holds 120,490 shares of Common Stock
28 Jul 2021	Form 3: Yamada Tadataka, Director Holds 124,097 shares of Common Stock
28 Jul 2021	Form 3: Russo Thomas Joseph, Chief Financial Officer
28 Jul 2021	Form 3: Holtzman Douglas, Chief Scientific Officer Holds 240,982 shares of Common Stock
28 Jul 2021	Form 3: NanoDimension III, L.p., 10% owner and 3 others
28 Jul 2021	Form 3: Richardson Charles E, See Remarks Holds 51,133 shares of Common Stock
28 Jul 2021	Form 3: Simpson Adam K., Director Holds 781,576 shares of Common Stock
28 Jul 2021	Form 3: Veneman Ann M, Director
28 Jul 2021	Form 3: Qiming U.s. Healthcare Fund II, L.p., Director and 2 others
28 Jul 2021	Form 3: Ra Capital MANAGEMENT, L.p., Director and 4 others
28 Jul 2021	Form 3: Adams Street Partners Llc, 10% owner
28 Jul 2021	Form 3: Sanofi, 10% owner
28 Jul 2021	Form 3: Cormorant Asset Management, Lp, 10% owner and 3 others

Comments